Medical Companies

Industry: Pharmaceuticals, Biotechnology
Founded in 2001, BioMachines is a privately held company that provides proven solutions for drug discovery through advanced automation. The Research Triangle-based company gives life sciences researchers the automation tools they need to accelerate the discovery and development of safe and efficacious new drugs. To assist researchers, we deliver sophisticated, vision-enabled, high-precision, nano liquid-handling capability to meet today’s demanding requirements. Our systems support pharmaceutical and biotechnology companies, contract research organizations, and academic, government and other non-profit research institutes to analyze the relationship between various complex biological processes and human ( www.bio-machines.com )

BioMachines Inc.
615 Davis Drive Suite 100
Research Triangle Park, North Carolina 27560
USA

Tel: (919) 883-0012

Industry: Pharmaceuticals, Biotechnology
Unigen is a leading natural products research and development company and proprietary ingredients supplier. The company is dedicated to the discovery of botanically derived therapeutic compounds that address consumer health needs and help improve the quality of human life. Its research and discovery process includes extensive work at both the human cell and gene level. Unigen (www.unigenpharma.com), and sister companies Aloecorp and Oasis Wellness Network, are subsidiaries of Univera, Inc. Unigen and Aloecorp each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical ( www.unigenpharma.com )

Unigen Pharmaceuticals , Inc.
2660 Willamette Drive NE
Lacey, Washington 98516
USA

Tel: (360) 486-8200
Fax: (360) 413-9135

Industry: Pharmaceuticals, Biotechnology
Molecular Insight Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics. The company’s product candidates target markets with significant unmet needs in cardiology, oncology, and neurology. Molecular Insight’s lead cardiology product candidate, Zemivaâ„¢ (iodofiltic acid I 123) is in development as a molecular imaging pharmaceutical for the diagnosis of insufficient blood flow to the heart, or cardiac ischemia. The company’s second lead product candidate, Azedraâ„¢, is in development for the diagnosis and treatment of neuroendocrine tumors. Molecular Insight Pharmaceuticals is based in Cambridge, Massachusetts. ( www.molecularinsight.com )

Molecular Insight Pharmaceuticals, Inc.
160 Second Street
Cambridge, Massachusetts 02142
USA

Tel: (617) 492-5554
Fax: (617) 492-5664

Industry: Pharmaceuticals, Biotechnology
AutoImmune is a biopharmaceutical company involved in the development of a new class of mucosally administered therapies for the treatment of autoimmune and cell-mediated inflammatory diseases and conditions. ( www.autoimmuneinc.com )

Autoimmune Inc
1199 Madia Street
Pasadena, California 91103
USA

Tel: (626) 792-1235
Fax: (626) 792-1236

Industry: Pharmaceuticals, Biotechnology
StemCyte, Inc., headquartered in Arcadia, California, intends to create the largest donor umbilical cord blood stem cell bank in the world. StemCyte and its subsidiaries are dedicated to providing high quality, cost-effective, stem cell transplantation and therapy to all patients in need. StemCyte, Inc.’s management team consists of medical, scientific, clinical laboratory, tissue typing, blood banking and stem cell professionals and experts, most of whom have been recruited from world-renowned medical institutions such as Harvard Medical School, UCLA, American Red Cross, City of Hope, and others. Because of its ability to deliver high quality and high quantity viable cord blood stem cells, StemCyte is a key choice for transplant centers around the ( www.stemcyte.com )

StemCyte , Inc.
400 Rolyn Place
Arcadia, California 91007
USA

Tel: (626) 821-9860
Fax: (626) 821-9660

Industry: Pharmaceuticals, Biotechnology
VioQuest Pharmaceuticals, Inc. acquires, develops, and commercializes targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, viral and autoimmune disorders. A pioneer in personalized therapeutics, VioQuest has two targeted therapeutics in clinical trials: VQD-001, an inhibitor of specific protein tyrosine phosphatases, has shown compelling preclinical activity in both renal and melanoma cancers and VQD-002 which has shown to inhibit the phosphorylation of Akt which can be seen in abnormal levels in breast, ovarian, colorectal, pancreatic, and hematologic ( www.vioquestpharm.com )

VioQuest Pharmaceuticals , Inc.
180 Mt. Airy Road Suite 102
Basking Ridge, New Jersey 07920
USA

Tel: (908) 766-4400
Fax: (908) 766-4455

Industry: Pharmaceuticals, Biotechnology
Acceleron is a privately held biopharmaceutical company focused on developing and commercializing regenerative therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases. The company’s scientific platform is based on its unique approach to harness the clinical potential of naturally-occurring tissue growth factors to treat diseases with significant unmet medical need. The company’s lead program is an anabolic bone agent being developed to reverse bone loss in diseases such as osteoporosis and cancer. Additionally, the company has therapeutic programs in the areas of muscle growth, angiogenesis and metabolic ( www.acceleronpharma.com )

Acceleron Pharma , Inc.
24 Emily Street
Cambridge, Massachusetts 02139
USA

Tel: (617) 576-2220
Fax: (617) 576-2224

Industry: Pharmaceuticals, Biotechnology
Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options. Saneron, a University of South Florida spin-out company is located at the Tampa Bay Technology Incubator. An affiliate of Cryo-Cell International, Inc. Saneron is committed to providing readily available, non-controversial, ethically acceptable cells, both stem cells and other cell types, for cellular therapies. Saneron has patented and patent-pending technology relating to our platform technology of: U-CORD-CELLTM – Umbilical cord blood SERT-CELLTM – Sertoli cells ( www.saneron-ccel.com )

Saneron CCEL Therapeutics , Inc.
3802 Spectrum Blvd. Suite 145
Tampa, Florida 33612
USA

Tel: (813) 977-7664

Industry: Pharmaceuticals, Biotechnology
RheoGene is developing a pipeline of indications in which RTS is the vehicle for regulated therapeutic gene delivery. Our lead program is malignant glioma, which is designed to demonstrate safety and efficacy of controlled therapeutic protein delivery to set the stage for applying RTS to other cancer and noncancer indications with a variety of therapeutic genes. We are also developing stem cell therapeutics to treat degenerative ocular disorders, a program funded in part by a NIST-ATP award. ReoGene’s proprietary RheoSwitch® Inducible Expression System and AttSite Recombinase gene targeting products are available through RheoGene directly and through products offered by leading commercial providers of research products and services. ( www.rheogene.com )

RheoGene Inc.
2650 Eisenhower Avenue
Norristown, Pennsylvania 19403
USA

Tel: (610) 650-8734
Fax: (610) 650-8755